MD Anderson and Phoenix SENOLYTIX Forge Strategic Cross-Licensing Partnership to Advance Inducible Switch Technologies in Cell and Gene Therapies
In a landmark development set to advance the frontier of cell and gene therapy, The University of Texas MD Anderson ...
